The First immunization Auto Disable Syringe manufactured in Pakistan by licensed manufacturing facility of AMSON’s Auto Disable Syringe Plant.
The First syringe brand registered by the Ministry of Health, Pakistan.
K1 has a patented design made under license from M/s Star Syringes, UK.
K1 Auto Disable (AD) syringe has a proven track record in both immunization and curative injection practices. The design is WHO (Performance Quality and Safety) compliant and K1 products are supplied to UNICEF and other UN Agencies.
The Amson ADS plant has been awarded ISO 13485 (2003), ISO 9001 (2008) & all the products have been CE marked (European Conformity).
Apple K1 is a syringe with a locking and breaking mechanism in the barrel so that it cannot be re-used. It’s a user friendly design.
Packed in Medical grade breathable printed poly paper on one side and transparent poly film on the other side.
EO sterilized on world class EO sterilization plant.
K1 is a flexible product with an established market. It is currently manufactured in 14 plants all across the developing world and K1 licensees sell directly to more than 40 countries.
The First syringe brand registered by the Ministry of Health, Pakistan.
K1 has a patented design made under license from M/s Star Syringes, UK.
K1 Auto Disable (AD) syringe has a proven track record in both immunization and curative injection practices. The design is WHO (Performance Quality and Safety) compliant and K1 products are supplied to UNICEF and other UN Agencies.
The Amson ADS plant has been awarded ISO 13485 (2003), ISO 9001 (2008) & all the products have been CE marked (European Conformity).
Apple K1 is a syringe with a locking and breaking mechanism in the barrel so that it cannot be re-used. It’s a user friendly design.
Packed in Medical grade breathable printed poly paper on one side and transparent poly film on the other side.
EO sterilized on world class EO sterilization plant.
K1 is a flexible product with an established market. It is currently manufactured in 14 plants all across the developing world and K1 licensees sell directly to more than 40 countries.